您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (9): 1-5.doi: 10.6040/j.issn.1671-7554.0.2014.271

• 基础医学 •    下一篇

干扰CD147表达抑制白血病细胞SHI-1增殖及移行

涂燕1,2, 李振江1, 汤爱平1, 费妍1, 李慧慧1, 李剑1, 贺文凤1   

  1. 1. 南昌大学第二附属医院血液科 江西省血液重点实验室, 江西 南昌 330006;
    2. 浙江大学金华医院血液科, 浙江 金华 321000
  • 收稿日期:2014-04-14 修回日期:2014-09-05 出版日期:2014-09-10 发布日期:2014-09-10
  • 基金资助:
    国家青年自然科学基金(30800490);江西省科技厅基金

RNAi-mediated silencing of CD147 inhibits the proliferation and invasion of leukemic cells SHI-1

TU Yan1,2, LI Zhenjiang1, TANG Aiping1, FEI Yan1, LI Huihui1, LI Jian1, HE Wenfeng1   

  1. 1. Department of Hematology, Second Hospital Affiliated to Nanchang University, Key Laboratory of Hematology in Jiangxi Province, Nanchang 330006, Jiangxi, China;
    2. Department of Hematology, Jinhua Hospital of Zhejiang University, Jinhua 321000, Zhejiang, China
  • Received:2014-04-14 Revised:2014-09-05 Online:2014-09-10 Published:2014-09-10
  • Contact: 李振江。E-mail:lzjdgh@163.com E-mail:lzjdgh@163.com

摘要: 目的 构建针对细胞外基质金属蛋白酶诱导因子(CD147)的慢病毒干扰载体,探讨干扰CD147表达后对白血病细胞系SHI-1细胞体外增殖、侵袭、转移能力的影响。方法 设计针对CD147的干扰序列片段,构建于慢病毒载体pGCSIL-GFP上,重组慢病毒载体与包装载体共转染293T细胞,收集病毒上清,测定病毒滴度。病毒上清感染SHI-1细胞,RT-PCR法检测CD147、MMP-2及MMP-9 mRNA表达,Western blotting法检测CD147蛋白水平;MTT法检测细胞体外增殖能力,体外SHI-1细胞与骨髓基质细胞共培养跨Matrigel基质胶检测SHI-1细胞的体外侵袭能力。结果 成功构建慢病毒干扰载体,获得重组慢病毒,滴度达1×109 TU/mL。病毒感染SHI-1细胞后,SHI-1/CD147i细胞的CD147 mRNA较感染阴性对照病毒的SHI-1/NC细胞下调86.7%,CD147蛋白表达下降91%,SHI-1/CD147i细胞MMP-2及MMP-9 mRNA表达较SHI-1/NC细胞分别下降78.3%和70.6%。SHI-1/CD147i细胞体外增殖能力较SHI-1/NC及SHI-1细胞明显下降;与骨髓基质细胞共培养24h后,SHI-1、SHI-1/NC、SHI-1/CD147i细胞移行至Transwell下层的细胞占接种细胞数比例分别为(18.2±2.5)%、(16.5±2.7)%、(4.5±1.2)%,SHI-1/CD147细胞移行能力显著低于SHI-1和SHI-1/NC细胞。结论 干扰SHI-1细胞的CD147表达后,通过下调MMPs表达抑制SHI-1细胞体内外增殖及移行能力,CD147可能成为治疗急性白血病的靶点。

关键词: 细胞增殖, 细胞外基质金属蛋白酶诱导因子, 急性单核细胞白血病细胞株, RNA干扰, 基质金属蛋白酶, 细胞移行

Abstract: Objective To construct lentivirus vector for RNA interference (RNAi) targeting extracellular matrix metalloproteinase inducer (CD147) and to investigate the role of CD147 gene on the proliferation and infiltration of a human monocytic leukemic cell line SHI-1. Methods The complementary shRNA targeting CD147 was synthesized, and connected with pGCSIL-GFP vector. The 293T cells were transfected with recombined viral vector, packing plasmid pHelper 1.0 and pHelper 2.0 using Lipfectamine 2000. Then the recombinant lentiviruses were collected and infected the SHI-1 cells. The expressions of CD147, MMP-2 and MMP-9 in SHI-1 cells were detected by real time PCR. The protein of CD147 was detected by Western blotting. The capability of proliferation and infiltration of SHI-1 cell were examined by MTT and trans-matrigel invasion assay co-cultured with leukemia BMSCs in vitro. Results The lentivirus containing the CD147 shRNA was constructed successfully. The titer of recombined virus was 1×109 TU/mL. The mRNA and protein of CD147 in SHI-1/CD147i cells decreased by 86.7% and 91% respectively after the SHI-1 cells were infected by the lentivirus containing the CD147 siRNA. The proliferation capability of SHI-1/CD147i cells significantly decreased compared with that of SHI-1 and SHI-1/NC cells. The mRNA expressions of MMP-2 and MMP-9 in SHI-1/CD147i cells were significantly lower than that in SHI-1/NC and SHI-1 cells. The SHI-1/CD147i cells demonstrated significantly lower invasion rate than SHI-1 cells and SHI-1/NC cells when co-cultured with BMSCs. Conclusion CD147 plays important roles in the leukemia cell proliferation and infiltration. CD147 should be a potential target for the treatment of acute leukemia.

Key words: matrix metalloproteinase, Extracellular matrix metalloproteinase inducer, RNA interference, Cell invasion, Acute monocytic leukemia cell line, Cell proliferation

中图分类号: 

  • R733.7
[1] Stenzinger A, Wittschieber D, von W M, et al. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer[J]. Human pathology, 2012, 43 (9): 1471-1481.
[2] Zeng W, Su J, Wu L, et al. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation[J]. Curr Mol Med, 2014, 14(1): 163-173.
[3] Li Z J, Chen Z X, Cen J N, et al. Direct contact with bone marrow stromal cells promote the invasions of SHI-1 leukemia cells[J]. Chin Med J, 2013, 126 (14): 2731-2735.
[4] Froehlich H, Fellmann M, Sueltmann H, et al. Large scale statistical inference of signaling pathways from RNAi and microarray data[J]. BMC Bioinformatics, 2007, 8: 386-400.
[5] Ma Y, Chan C Y, He M L. RNA interference and antiviral therapy[J]. World J Gastroenterol, 2007, 13(39): 5169-5179.
[6] Jazag A, Ijichi H, Kanai F, et al. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-β[J]. Oncogene, 2005, 24(4): 662-671.
[7] Imamura T, Kanai F, Kawakami T, et al. Proteomic analysis of t heTGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression[J]. Biochem Biophys Res Commun, 2004, 318 (1): 289-296.
[8] 黄灵芝, 赵敬湘, 刘淑静, 等. CD147 对白血病细胞U937生长和肿瘤形成的影响[J]. 生物技术通讯. 2008, 19(2): 203-206. HUANG Lingzhi, ZHAO Jingxiang, LIU Shujing, et al. The effect of CD147 on growth and tumorigenicity of leukemic U937 cells[J]. Letters in Biotechnology. 2008, 19(2): 203-206.
[9] Nabeshima K, Suzumiya J, Nagano M, et al. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas[J]. J Pathol, 2004, 202(3): 341-351.
[10] Fu J F, Fu J F, Chen X Q, et al. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia[J]. Jpn J Clin Oncol, 2010, 40(11): 1046-1052.
[11] Beesley A H, Cummings A J, Freitas, et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure[J]. Br J Haematol, 2005, 131(4): 447-456.
[12] Thorn C S, Noack F, Feller A C, et al. Application of newly developed tissue-arrays to study EMMPRIN (CD147) expression in malignant Non-Hodgkin lymphoma[J]. Cancer Genomics Proteomics, 2004, 1(1): 45-52.
[13] Arendt B K, Walters D K, Wu X, et al. Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation[J]. Leukemia, 2012, 26(10): 2286-2296.
[14] Xu J, Shen Z Y, Chen X G, et al. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation[J]. Hepatology, 2007, 45(2): 269-276.
[1] 陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[2] 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[3] 王芳,陈华,商丽红,李茹月,李咏梅,杨玉娥,哈春芳. U0126对子宫内膜异位症大鼠MEK/ERK/NF-κB通路及增殖侵袭的影响[J]. 山东大学学报 (医学版), 2021, 59(9): 148-154.
[4] 张小红,周云,杜秋莹,任慧欣,王超群. Atg7-siRNA通过调节精氨酸循环干扰食管癌ECA109细胞放疗敏感性[J]. 山东大学学报 (医学版), 2021, 59(4): 28-34.
[5] 王正阳,夏艳,师凯旋,陶琨,王小杰. 曲美替尼在卵巢癌中对PAX8的表达作用[J]. 山东大学学报 (医学版), 2021, 59(10): 25-31.
[6] 杜甜甜,李娟,赵颖慧,段伟丽,王景,王允山,杜鲁涛,王传新. 长链非编码RNA LINC02474在结直肠癌中的表达特征及对细胞增殖的影响[J]. 山东大学学报 (医学版), 2021, 59(10): 59-69.
[7] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14.
[8] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32-37.
[9] 张炜悦, 李亚光, 刘恩令, 王伟杰, 魏靖文, 荆楠. microRNA519D与基质金属蛋白酶2在36例子痫前期患者胎盘组织中的表达及意义[J]. 山东大学学报 (医学版), 2020, 58(1): 54-59.
[10] 赵鸿渐,周继军,苏庆亮,赵硕,李玉明. 胃癌间充质干细胞与SGC-7901荷瘤鼠肿瘤进展的相关性[J]. 山东大学学报 (医学版), 2019, 57(9): 69-73.
[11] 阎慧丽,魏慕筠,颜磊,赵跃然. FK506结合蛋白52对人子宫内膜间质细胞增殖作用的影响[J]. 山东大学学报 (医学版), 2019, 57(2): 80-87.
[12] 李孝峰,杜晓益,刘海南,刘承,范医东. 小檗碱对人肾细胞癌细胞增殖、凋亡、DNA断裂及损伤修复的影响[J]. 山东大学学报 (医学版), 2018, 56(3): 54-59.
[13] 黄平,张坤,李芳,黄国宝,延冰,肖东杰,汪运山,刘华. 脐带和脂肪源性间充质干细胞生物学特性比较[J]. 山东大学学报 (医学版), 2018, 56(3): 72-78.
[14] 李杰,何东,张睿,杨帆,冯少滨,杨依航,辛涛. 核转运蛋白α2在胶质瘤中的表达及对其生物学行为的影响[J]. 山东大学学报 (医学版), 2018, 56(12): 47-54.
[15] 陈希彦,王琪,顾伟亭,文勇. 干扰TAZ基因对舌鳞癌细胞CAL27增殖凋亡的影响及其机制[J]. 山东大学学报 (医学版), 2018, 56(10): 79-85.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!